6533b873fe1ef96bd12d551e
RESEARCH PRODUCT
P2.04-11 An IL-8/IFN-gammma/NLR Plasma Score to Predict Nivolumab Efficacy in Patients with NSCLC
A. RussoVeronica HuberH. Soto ParraL. LalliFrancesco PassigliaLicia RivoltiniAgata CovaS. Ferrosubject
Pulmonary and Respiratory MedicineOncologymedicine.medical_specialtyOncologybusiness.industryInternal medicineMedicineIn patientInterleukin 8Nivolumabbusinessyear | journal | country | edition | language |
---|---|---|---|---|
2018-10-01 | Journal of Thoracic Oncology |